ACP-105

ACP-105 is part of a class of molecules referred to as selective androgen receptor modulators (SARMs). SARMs may advance the standard of treatment for a variety of disorders including muscle-wasting conditions and osteoporosis, with fewer side effects as compared to current treatments based on testosterone replacement. ACP-105 has exhibited promising pharmacological properties and a favorable safety profile.

It is one of the newer SARMs.

ACP-105 works similarly to other SARMs because it interacts with androgen receptors in the bones and muscles without affecting sexual tissue or liver enzymes.

ACP-105 is a partial agonist. Full agonists induce greater levels of suppression, but are more potent. With ACP-105 in particular, being a partial agonist it would result in less suppression, although it will also likely be weaker than several SARMs on a mg:mg comparison, but referring back to the anabolic: androgenic rating of ACP-105 (3.19:1). It is assumed that a higher dose of ACP-105 may yield effects formidable to that of Testosterone, with a very minimal presence of negative androgenic side effects.

The main things to expect are a significant increase in strength, muscle gains and perhaps even endurance. Due to the high anabolic activity that ACP has, can definitely expect good results.

STORAGE CONDITIONS: Store at room temperature in a dry and cool place, out of reach of children. Not to be consumed by children, pregnant and nursing women, people suffering from liver or kidney diseases, and with allergies to any of the supplement compounds.